↓ Skip to main content

Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration A Randomized Phase 2 Trial

Overview of attention for article published in Ophthalmology, July 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
6 news outlets
twitter
18 X users
patent
4 patents

Citations

dimensions_citation
321 Dimensions

Readers on

mendeley
286 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration A Randomized Phase 2 Trial
Published in
Ophthalmology, July 2019
DOI 10.1016/j.ophtha.2019.07.011
Pubmed ID
Authors

David S Liao, Federico V Grossi, Delphine El Mehdi, Monica R Gerber, David M Brown, Jeffrey S Heier, Charles C Wykoff, Lawrence J Singerman, Prema Abraham, Felix Grassmann, Peter Nuernberg, Bernhard H F Weber, Pascal Deschatelets, Robert Y Kim, Carol Y Chung, Ramiro M Ribeiro, Mohamed Hamdani, Philip J Rosenfeld, David S Boyer, Jason S Slakter, Cedric G Francois

X Demographics

X Demographics

The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 286 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 286 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 30 10%
Student > Bachelor 22 8%
Other 20 7%
Student > Ph. D. Student 17 6%
Student > Doctoral Student 15 5%
Other 59 21%
Unknown 123 43%
Readers by discipline Count As %
Medicine and Dentistry 64 22%
Biochemistry, Genetics and Molecular Biology 22 8%
Unspecified 12 4%
Pharmacology, Toxicology and Pharmaceutical Science 8 3%
Nursing and Health Professions 7 2%
Other 33 12%
Unknown 140 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 57. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 October 2023.
All research outputs
#758,242
of 25,743,152 outputs
Outputs from Ophthalmology
#204
of 6,822 outputs
Outputs of similar age
#16,038
of 360,489 outputs
Outputs of similar age from Ophthalmology
#2
of 88 outputs
Altmetric has tracked 25,743,152 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,822 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.7. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,489 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 88 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.